The nano-enhanced antibiotic effectively erradicates bacteria from lung cells (bottom line).
Novel nanotech improves cystic fibrosis antibiotic by 100,000-fold
World-first nanotechnology developed by the University of South Australia could change the lives of thousands of people living with cystic fibrosis (CF) as groundbreaking research shows it can improve the effectiveness of the CF antibiotic Tobramycin, increasing its efficacy by up to 100,000-fold.
The new technology uses a biomimetic nanostructured material to augment Tobramycin – the antibiotic prescribed to treat chronic Pseudomonas aeruginosa lung infections in severe cases of CF – eradicating the infection in as little as two doses.
In Australia, cystic fibrosis (CF) affects one in 2500 babies – or one baby born every four days – causing severe impairments to a person’s lungs, airways and digestive system, trapping bacteria and leading to recurrent infections. Lung failure is the major cause of death for people with CF.
The UniSA research team, which includes Professor Clive Prestidge, Dr Nicky Thomas, and PhD candidate, Chelsea Thorn, says the discovery could transform the lives of people living with CF.
“CF is a progressive, genetic disease that causes persistent, chronic lung infections and limits a person’s ability to breathe,” Thorn says.
“The disease causes thick, sticky mucus to clog a person’s airways, attracting germs and bacteria, such as Pseudomonas aeruginosa, which leads to recurring infections and blockages.
“Tobramycin is commonly used to treat these infections but increasingly antibiotics are failing to make any significant difference to lung infections, leaving sufferers requiring life-long antibiotic therapy administered every month.
“Our research successfully treats advanced human cell culture lung infections using nano-enhanced Tobramycin and shows how it can eradicate serious and persistent infections after only two doses.
“This could be a real game-changer for people living with CF.”
Researchers enhanced the Tobramycin with a biometric, nanostructured, lipid liquid crystal nanoparticle (LCNP)-based material, testing it on a new lung infection model to showcase its unique ability to penetrate the dense surface of the bacteria and kill the infection.
Dr Nicky Thomas, who is supported by a Mid-Career Fellowship from The Hospital Research Foundation Group, says the discovery continues the global battle to eradicate and prevent Pseudomonas aeruginosa.
Tobramycin works by inhibiting the synthesis of bacteria and causing cell membrane damage. Yet, as it’s a concentration-dependent antibiotic, achieving a sufficiently high concentration is critical,” Dr Thomas says.
“Our technology improves the performance of Tobramycin without increasing the toxicity of the drug, so what we’re doing is a far more effective and efficient treatment for chronic lung infections.”
The technology is currently entering pre-clinical trials and hopes to be on the market in the next five years.
Original Article: Novel nanotech improves cystic fibrosis antibiotic by 100,000-fold
More from: University of South Australia
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Nano-enhanced Tobramycin
- Biocompatible nanoparticles modified with ATP can enhance systemic delivery of cancer immunotherapy
More information: Soonbum Kwon et al, Systemic Delivery of Paclitaxel by Find-Me Nanoparticles Activates Antitumor Immunity and Eliminates Tumors, ACS Nano (2024). DOI: 10.1021/acsnano.3c11445 ...
- Another royal image flagged by leading photo agency as being ‘digitally enhanced’
Getty Images flagged the official portrait from Prince Archie’s christening as “digitally enhanced.” CHRIS ALLERTON HANDOUT/EPA-EFE/REX Getty only said the stately portrait taken at Windsor ...
- Android phones with Gemini Nano could gain another handy on-device feature
Google’s Gemini Nano model could soon power on-device article summaries. Gemini Nano is the mobile-optimized version of the Google Gemini large language model. The Pixel 8 Pro and Galaxy S24 ...
- Google confirms Gemini Nano will not come to the Pixel 8
Google says its Gemini Nano LLM isn't coming to the Pixel 8 due to hardware limitations, but may come to more high-end devices in the future. It's disappointing considering the only difference ...
- New nano-microscope enables simultaneous measurement of nano-composite material properties
Dr. Eun Seong Lee, a principal researcher from the KRISS Material Property Metrology Group, said, "This achievement is the culmination of our research experience in nano-measurement since 2015. We ...
Go deeper with Google Headlines on:
Nano-enhanced Tobramycin
[google_news title=”” keyword=”nano-enhanced Tobramycin” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Nano-enhanced drugs
- Nano-Chemicals Market Segmentation Synergy Enhancing Strategies for Effective Market Targeting
This market report is an excellent fusion of qualitative and quantitative data emphasizing major industry changes, business and competitor difficulties in gap analysis, and potential new possibilities ...
- Researchers create biocompatible nanoparticles to enhance systemic delivery of cancer immunotherapy
Researchers are enhancing immunotherapy effects against malignant tumors by developing and validating patent-ending poly (lactic-co-glycolic acid), or PLGA, nanoparticles modified with adenosine ...
- North America Nanotechnology Drug Delivery Market Exhibits 8.1% CAGR, Fueled by Advancements in Precision Medicine
The "North America Nanotechnology Drug Delivery Market Size, Share & Trends Analysis Report By Formulation (Polymer-Based Nanomedicine, Lipid-Based Nanomedicine, Nanocrystals, and Others), By ...
- Silk peptide nanoparticles show promise for enhancing targeted cancer therapy through dual-drug delivery
Building on this foundation, researchers from Wuhan University and Anhui Medical University in China have developed a unique drug delivery system using silk peptide nanoparticles. As reported in the ...
- SN BioScience received US FDA Orphan Drug Designation for its Nano Anti-Cancer Drug 'SNB-101' on Pancreatic Cancer
SNB-101 is an anticancer agent that is the world's first nanoparticle formulation of the anticancer drug SN-38. It uses a delivery system sophisticatedly designed via dual nano-micelle technology ...
Go deeper with Google Headlines on:
Nano-enhanced drugs
[google_news title=”” keyword=”nano-enhanced drugs” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]